Sex-Related Pathophysiological Mechanisms May Be Present Before Symptoms of HFpEF Develop
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15228 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von B Wong und 6 weiteren Autor:innen. Beteiligte Einrichtung: St. Vincent's University Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Stroke Volume, Vascular Stiffness, Ventricular Function, Left, Heart Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Understanding sex-related cardiovascular differences in those with pre-HFpEF (asymptomatic with normal ejection fraction, elevated natriuretic peptides and structural or functional heart disease) could help explain why females are more likely to develop symptomatic HFpEF compared with males. This study analyses sex-related cardiovascular differences in pre-HFpEF, including measures of cardiovascular stiffness and vascular resistance derived from cardiac magnetic resonance imaging (CMR) and Doppler echocardiography. Methods and results This post hoc analysis of the PARABLE trial enrolled 250 patients with pre-HFpEF. CMR and Doppler echocardiography were used to estimate baseline markers of cardiovascular stiffness and resistance, including effective arterial elastance (EAE), systemic vascular resistance (SVR), total arterial compliance (TAC), left ventricular end diastolic pressure (LVEDP) and left ventricular end diastolic chamber stiffness index (LVSId). The population median age was 72.0 [IQR 68.0; 77.0] years and 38.4% were female. Both sexes had a similar age, blood pressure, HbA1c, renal function and H2FPEF score. Fewer female participants had a diagnosis of diabetes and coronary artery disease. When adjusted for age, hypertension, diabetes, obesity and vascular disease, female participants had higher pulse pressures (62.1 (SD 15.3) vs. 60.1 (SD 12.5) mmHg, P < 0.001) as well as higher median [IQR] levels of LDL-cholesterol (2.50 [2.10; 3.25] vs. 2.00 [1.60; 2.40] mmol/L, P < 0.001), EAE (1.55 [1.26; 1.84] vs. 1.26 [1.05; 1.51] mmHg/mL/m2, P < 0.001), SVR (1609 [1288; 1887] vs. 1336 [1132; 1734] mmHg/mL/min2, P = 0.001), LVEDP (18.5 [17.2; 20.1] vs. 18.0 [16.9; 19.3] mmHg, P < 0.001) and LVSId (0.28 [0.24; 0.31] vs 0.24 [0.20; 0.29] mmHg/mL/m2, P < 0.001) than males. Females had higher median [IQR] NT-proBNP (176 [95.8; 286] vs. 127 [81.5; 242] pg/mL, P < 0.001) and lower median [IQR] TAC (1.24 [0.99; 1.58] vs. 1.55 [1.18; 1.91] mL/mmHg, P < 0.001) than male participants.
Conclusions
Markers of elevated cardiovascular stiffness and vascular resistance are seen in female versus male participants with pre-HFpEF, suggesting that sex-related pathophysiological mechanisms are present before symptoms of HF develop.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- St. Vincent's University Hospital, Dublin, Ireland.
- School of Medicine, University College Dublin, Dublin, Ireland.
- School of Pharmacy, Trinity College Dublin, Dublin, Ireland.
ORCID-Profile: M Ledwidge
Zitieren
APA
Wong, B., Dodd, J. D., Gallagher, J., Dyer, B., Ryan, C., McDonald, K., & Ledwidge, M. (2025). Sex-Related Pathophysiological Mechanisms May Be Present Before Symptoms of HFpEF Develop. ESC Heart Failure. https://doi.org/10.1002/ehf2.15228
Vancouver
Wong B, Dodd JD, Gallagher J, Dyer B, Ryan C, McDonald K, et al. Sex-Related Pathophysiological Mechanisms May Be Present Before Symptoms of HFpEF Develop. ESC Heart Failure. 2025. doi:10.1002/ehf2.15228
BibTeX
@article{Wong2025,
author = {Wong, B and Dodd, J D and Gallagher, J and Dyer, B and Ryan, C and McDonald, K and Ledwidge, M},
title = {Sex-Related Pathophysiological Mechanisms May Be Present Before Symptoms of HFpEF Develop},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15228}
}
EUVIMED